0% READ
FULL TEXT
INTRODUCTION
Ayurveda, the traditional system of Indian medicine, emphasises the use of freshly made formulations for best therapeutic results. Kashaya (decoction) stands out due to its high extractive properties, fast absorption, and potency. According to historical writings such as Sharngadhara Samhita and Bhaishajya Ratnavali, Kashaya is made by boiling the necessary herbal ingredients in water until the volume is reduced to one-eight which ensures the release of active phytoconstituents into the medium.
The pharmaceutical industry has created ready-made bottled Kashaya formulations for consumer convenience in response to the growing demand for Ayurvedic medicines worldwide. However, maintaining consistency, stability, and therapeutic efficacy has become more difficult as a result of these formulations' commercialisation. Their chemical makeup and pharmacological action can be greatly impacted by variations in raw material quality, processing techniques, preservatives, and storage time.
Patolkaturohinyadi Kashaya is one the most potent classical Ayurvedic Formulation. This decoction is prepared with Patola (Trichosanthes dioica), Katurohini (Picororhiza kurroa) Chandan (Santalum album), Murva (Marsdenia tenacissima) Guduchi (Tinospora cardifolia) and Patha (Cissampelos pareira) it helps in alleviating Kapha And Pitta disorders, skin diseases (Kustha), Fever (Jawara), Poisoning (Visha), Vomiting (Vami), Loss of taste (Arochak) and jaundice (kamala) and other Pitta disorders due to its Tikta rasa(bitter taste ) and sheet veerya (cool potency) and pitta- kaphashamka properties (Phartale, 2025; Paradakar, 2002).
Because of the formulation's therapeutic value, it is crucial to make sure that commercial Kashaya preparations meet quality requirements as of freshly made decoctions. According to the Ayurvedic Pharmacopoeia of India (API) criteria, this study intends to do a comparative evaluation of two marketed samples and one freshly prepared sample of Patolakaturohiniyadi Kashaya, with an emphasis on physicochemical and phytochemical standardisation characteristics.
MATERIALS AND METHODS
Sample Collection
Three samples of Patolakaturohiniyadi Kashaya were selected from different sources to ensure a comparative evaluation. Sample A was obtained as a market sample from a GMP certified company, while sample B comprised a market formulation sourced from another GMP certified company. Sample C was freshly prepared in house strictly in accordance with classical textual method, at Pathaya unit of KAHER’s shri BMK Ayurveda Mahavidyalaya, Belagavi.
Method of Preparation
Decoction was prepared using 1 part of patolakaturohiniyadi Kwatha churna (course powder) and 16 parts of water was added and then boiled on medium flame (95-105ºC) till it get reduced to 1/8th part. Then Kashaya (decoction) was filtered and submitted for the analysis. (Sharangdhara, 2004).
Analytical Parameters
All samples were evaluated for organoleptic parameters (form, colour, odour, and taste) and physicochemical parameters (pH, specific gravity, and total solids) (Ayurvedic Pharmacopoeia of India [API], 2008). Preliminary phytochemical screening was carried out to detect carbohydrates, sugars, proteins, amino acids, steroids, flavonoids, alkaloids, tannins, and glycosides (Khandelwal, 2012). Further analysis included Thin Layer Chromatography (TLC) profiling, quantification of total flavonoid (Laoung-On et al., 2021), and phenolic content (Singleton and Rossi, 1965), microbial count assessment, and evaluation of antibacterial activity to assess quality, safety, and bioactivity of the samples.
RESULTS
Organoleptic Parameters
The following characters are constantly reported in the macroscopic description of PatolkaturohinyadiKashaya. Each of the three samples is in the form of Kashaya and has a characteristic odour, which refers to the natural scent of the herbal component. Tests A and B Both are dark brown in colour however; Sample C is brown. The taste of all three samples is bitter.
Thin Layer Chromatography
The alcoholic extract of Patolakaturohinyadi Kashaya was chromatographed using a mobile phase of toluene: ethyl acetate (7:3). The existence of several phytochemical components was confirmed by the three samples' numerous resolved bands under short-wave UV. Rf values for Sample A, Sample B, and Sample C were 0.18, 0.44, 0.60, and 0.84, 0.15, 0.36, 0.58, and 0.82, respectively. Sample B displayed a single notable band at 0.63 under long-wave UV, while Sample A displayed three more bands at 0.12, 0.27, and 0.40. Sample C did not exhibit any long-wave bands. Patolakaturohinyadi Kashaya's distinctive chromatographic fingerprint was established by the TLC profiles of all samples, which generally showed similar patterns with slight differences.
Microbial count
All the three of the Patolkaturohinyadi Kashaya tested Sample met the Qualitative microbiological requirements, demonstrating the absence of, E. coli, Staphylococcus Aureus and Pseudomonas aeruginosa in 100 mL of the formulation. Sample A and B did not exhibit any bacterial or fungal growth in the quantitative microbiological limit test, staying below the permissible limits of 50-500 cfu/mL of bacterial count and 10-100 cfu/mL for total fungal count. Sample C showed a total fungal count of 15 cfu/mL and a total bacterial count of 45 cfu/mL, both of which were within the allowed limit. Overall. Every Sample satisfied the standards of microbiological quality
Anti-Bacterial Activity
Patolkaturohiniyadi Kashaya: Antibacterial activity against Escherichia. Coli, Staphylococcus Aureus, Streptococcus pyogens and Pseudomonas aeruginosa was determined using the cup-plate diffusion method at doses ranging from 5 to 100 mg/mL (Bauer et al., 1966; Indian Pharmacopoeia Commission, 2018).
Sample A showed zones of inhibition against Staphylococcus aureus and Streptococcus pyogens with the greatest inhibition at 100 mg/mL measuring 25 mm and 30 mm respectively. At 75 mg/mL, zones of inhibition of 18 mm for Staphylococcus aureus and 25 mm for Streptococcus pyogens were reported, while Streptococcus pyogens alone showed inhibition of 18 mm at 50 mg/mL. At doses as low as 25 mg/mL, no inhibitory action was found.
Sample B showed antibacterial activity against Escherichia coli, Staphylococcus pyogens at 100 mg/mL, with zones of inhibition of 28 mm, 28 mm and 32 mm respectively. At 75mg/mL, inhibition zones of 2 0 mm (E. coli), 22 mm (S. aureus) and 28 mm (S. pyogens) were detected, while at 50 mg/mL inhibition was only noted against Staphylococcus aureus (19 mm) and Streptococcus pyogens (20 mm).
Sample C showed antibacterial activity against Staphylococcus aureus and Streptococcus pyogenes with zones of inhibition of 22 mm and 24 mm at 100 concentrations, 20 mm at 75 and 18 mm and 19 mm at 50 indicating dose dependent activity. No zone of inhibition was observed at 25,10, and 5 concentrations. The formulation showed no antibacterial activity against Escherichia coli and Pseudomonas aeruginosa at any concentration. The control group showed no zone of inhibition
DISCUSSION
The present study demonstrated noticeable differences between freshly prepared and commercially available samples of Patolakaturohiniyadi Kashaya, highlighting the influence of ingredient composition, processing methods, and storage conditions on the overall characteristics of the formulation. Although similarity in organoleptic properties confirmed the identity of the formulation, variations in colour among the samples indicate the possible impact of manufacturing practices and duration of storage.
Physicochemical evaluation revealed that the freshly prepared Kashaya exhibited a nearly neutral pH and lower total solid content, which is consistent with the classical Ayurvedic principle that freshly prepared decoctions possess better therapeutic potential. In contrast, the marketed samples showed a comparatively acidic pH and higher total solids, which may be attributed to concentration during large-scale manufacturing, addition of preservatives, and prolonged storage.
Preliminary phytochemical screening confirmed the presence of major constituents such as flavonoids and tannins in all samples. However, variations in certain secondary phytochemicals suggest differences in raw material quality, ingredient composition, and manufacturing procedures. Label comparison further revealed variations in ingredients, as Santalum album was present in Samples A and C but absent in Sample B, while Marsdenia tenacissima/Cissampelos pareira was present in Sample A but absent in Samples B and C. These compositional differences may have contributed to the qualitative and quantitative phytochemical variations observed.
The comparatively lower flavonoid content observed in Sample C may be attributed to differences in the proportion or quality of flavonoid-rich raw drugs, possible degradation of flavonoids during processing or storage, and variations in extraction efficiency during preparation, as flavonoids are known to be sensitive to heat, light, and oxidation.
Thin Layer Chromatography (TLC) profiling further supported the authenticity of the formulations despite the compositional differences. The higher phenolic and flavonoid content observed in commercial Kwatha compared to the freshly prepared sample may be due to concentration during large-scale manufacturing, improved extraction efficiency, and the use of dried and stored raw materials that facilitate the release of phenolic constituents. The increased phenolic and flavonoid content in marketed samples may also contribute to enhanced antimicrobial activity, as reflected by the detectable antibacterial effects (Tables 1-4).
| Sl. No. | Sample A (Market) | Sample B (Market) | Sample C (Fresh) |
|---|---|---|---|
| 1 | Murva Marsdenia tenacissima (Roxb) Moon | Agaru Aquilaria agallocha Roxb. | Patha Cyclea peltata Hook. Fil and Thoms |
| 2 | Guduchi Tinospora cardifolia (Thunb.) Miers | Guduchi Tinospora cardifolia (Thunb.) Miers | Guduchi Tinospora cardifolia (Thunb.) Miers |
| 3 | Patha Cissampelos pareira L. | Murva Chonemorpha fragrans (Moon) Alston | Murva Chonemorpha fragrans (Moon) Alston |
| 4 | Patola Trichosanthes dioica Roxb. | Patola Trichosanthes lobata Roxb. | Patola Trichosanthes cucumerina Roxb. |
| 5 | Katuki Picrorhiza kurroa Royle ex Benth | Katuki Picrorhiza kurroa Royle ex Benth | Katuki Picrorhiza kurroa Royle ex Benth |
| 6 | Chandana Santalum album L. | Patha Cyclea peltata Hook. Fil and Thoms | Chandana Santalum album L. |
| Tests | Sample A | Sample B | Sample C |
|---|---|---|---|
| Specific Gravity | 1.045 | 1.053 | 1.0128 |
| pH | 5.14 | 5.02 | 6.34 |
| Total solids | 15.021% | 16.836% | 4.149% |
| Extracts | Sample A | Sample B | Sample C |
|---|---|---|---|
| Carbohydrates | + | + | + |
| Reducing Sugar | + | + | + |
| Monosaccharides | + | + | + |
| Pentose sugar | - | - | - |
| Non reducing sugar | - | - | + |
| Hexose Sugar | - | - | - |
| Proteins | - | - | - |
| Amino Acids | + | - | + |
| Steroids | - | - | - |
| Flavonoids | + | + | + |
| Alkaloids | - | - | - |
| Tannins | + | + | + |
| Cardiac Glycosides | + | - | + |
| Anthraquinone Glycosides | - | - | - |
| Saponin Glycosides | + | + | - |
| Sample | Mean Phenolic Content (mg GAE/mL) | Mean Flavonoid Content (ug QE/mL) |
|---|---|---|
| Sample A | 3.86 | 851.3 |
| Sample B | 4.53±0.00 | 957.71±4.08 |
| Sample C | 0.89±0.01 | 95.11±6.55 |
Patolakaturohiniyadi Kashaya is traditionally indicated in the management of Kushtha, Twak Vikara, Jwara, and Pitta-Kapha predominant disorders, where its Tikta-pradhana dravyas contribute to detoxification, anti-inflammatory, and antimicrobial actions. Therefore, maintaining the quality and phytochemical consistency of this formulation is essential to ensure its therapeutic effectiveness in clinical practice.
Overall, the findings highlight that variations in ingredient composition, processing methods, and storage conditions play a significant role in determining the physicochemical and phytochemical characteristics of both freshly prepared and commercially available formulations.
CONCLUSION
Freshly prepared Patolkaturohiniyadi Kashaya aligns more closely with traditional Ayurvedic principles, whereas commercial formulations exhibit better stability and antibacterial activity. Variations in ingredient composition and processing highlight the need for proper standardization to maintain therapeutic consistency between classical and marketed preparations.
